Silicon photonics spent decades as the clever lab demo in search of a board‑level use case. Now, as AI data centers strain grids and mint new optics billionaires in Shenzhen and Hong Kong, that “solution in search of a problem” has finally…
Modular Medical (MODD) has cleared a crucial regulatory hurdle that positions its Pivot insulin patch pump as a potential game-changer in the $7 billion diabetes technology market, with FDA 510(k) clearance paving the way for commercial shipments by the end of Q2…
The United States’ latest move into quantum computing reads less like a science project and more like a sprawling, government-run portfolio spanning semiconductors, steel, nuclear power and rare earth metals—just with a few more qubits than usual.
Quantum Becomes the New National…
Global AI spending is barreling toward the trillion‑dollar mark faster than Wall Street’s models can refresh, and the odds are high that current estimates still understate the size of the build‑out. Nokia’s (NOK) new AI Networking Innovation Lab is one of the…
U.S. stocks extended their rebound on Thursday, May 21, 2026, with investors leaning back into risk as hopes for a U.S.–Iran agreement tempered recent geopolitical anxiety and markets digested a dense slate of Fed commentary and macro data. Gains were broad-based across…
For a nation that prides itself on independence, relying on foreign sources for more than 95% of its rare earth elements is less a strategy and more a vulnerability. These minerals—quietly embedded in everything from electric vehicles to missile guidance systems—have become…
For a technology widely cast as the villain in the modern labor story, artificial intelligence may be preparing for a reputational turnaround. According to LPL Financial Chief Economist Jeffrey Roach, the narrative of mass job displacement could be missing a more nuanced—and…
Airlines and AI servers stole the S&P 500 spotlight today, with United Airlines (UAL), Delta Air Lines (DAL), Super Micro Computer (SMCI) and the cruise lines Carnival (CCL) and Norwegian Cruise Line (NCLH) staging the kind of synchronized rally that makes index…
Stifel just initiated coverage during National Eosinophil Awareness Week on Eupraxia Pharmaceuticals (EPRX) with a Buy rating and a 25 dollar price target—roughly four times where the stock changed hands around the report—on the view that a sleepy drug‑delivery story is about…
SpaceX’s long-awaited leap to the public markets is finally underway, and Wall Street is treating it less like a traditional IPO and more like the financial equivalent of a rocket launch countdown. With a Nasdaq listing planned under the ticker “SPCX,” Elon…